A clinical study performed in 2006 to evaluate the gene expression of adult acute myeloid leukemia (AML) showed high MDR1/ABCB1 and BCRP/ABCG2 expression in a subset of patients with the worst overall survival and high drug resistance [19]. This evidence concerns the gene ABCB1 and acute myeloid leukemia.